Neurofibromatosis type 1 is a complex autosomal dominant disorder caused by germline
mutations in the NF1 tumour suppressor gene. Nearly all individuals with neurofibromatosis …

Neurofibromatosis type 1 is a relatively common genetic disease, with a prevalence ranging
between 1/3000 and 1/6000 people worldwide. The disease affects multiple systems with …

Neurofibromatosis 1 (NF1) is a multisystem disorder characterized by multiple café au lait
macules, intertriginous freckling, multiple cutaneous neurofibromas, and learning disability …

ABSTRACT Neurofibromatosis type 1 (NF1) is one of the most frequent genetic disorders,
affecting 1: 3,000 worldwide. Identification of genotype–phenotype correlations is …

Objective To present the current terminology and natural history of neurofibromatosis 1
(NF1) cutaneous neurofibromas (cNF). Methods NF1 experts from various research and …

Background Neurofibromatosis 2 (NF2) is an autosomal-dominant tumour predisposition
syndrome characterised by bilateral vestibular schwannomas, considerable morbidity and …

Objective: To test, within a single-blind randomized controlled trial, the feasibility,
acceptability, efficacy, and durability of a mind–body program (the Relaxation Response …

Importance Neurofibromatoses (NF; NF1, NF2, and schwannomatosis) are hereditary tumor
predisposition syndromes with a risk for poor quality of life (QOL) and no evidence-based …

Neurofibromatosis (NF) and schwannomatosis (SWN) are genetic conditions characterized
by the risk of developing nervous system tumors. Recently revised diagnostic criteria include …

Background There is scarce data on the quality of life of people with neurofibromatosis type
1 (NF1) and type 2 (NF2) in Canada. Methods A cross-sectional study of adults with NF1 and …